Synergistic interaction between anti-allergic drug and cationic/anionic surfactants–Experimental and theoretical analysis

A green and highly sensitive microwell spectrofluorimetric method with high throughput for the determination of pemigatinib based on dual fluorescence enhancement by photoinduced electron transfer blocking and micellization: Application to the analysis of tablets, content uniformity testing, and human plasma

Pemigatinib (PGT) is a recently FDA-approved small molecule kinase inhibitor used for the treatment of relapsed or refractory myeloid/lymphoid neoplasms in adults. This study introduces the development of a first microwell spectrofluorimetric method (MW-SFM) for quantifying PGT in FDA-approved tablets and plasma samples. The method utilized the enhancement of PGT's weak native fluorescence by blocking photoinduced electron transfer (PET) and micellization with sodium lauryl sulfate (SLS). The MW-SFM was performed in 96-microwell plates, and fluorescence signals were measured using a fluorescence microplate reader with excitation at 290 nm and emission at 350 nm. The method exhibited a linear range of 2-250 ng mL-1, and a limit of quantitation was 6.5 ng mL-1. The accuracy and precision of the method were confirmed with recovery rates ranging from 96.5% to 102.8% and relative standard deviations of 1.52% to 3.51%. The MW-SFM successfully analyzed Pemazyre® tablets, assessed content uniformity, and analyzed PGT-spiked human plasma samples. The greenness of the MW-SFM was verified using three different metric tools. In conclusion, the proposed MW-SFM is a valuable tool in supporting quality assessment of dosage forms, conducting pharmacokinetic studies, and monitoring therapeutic outcomes.

Dual fluorescence enhancement of loratidine by photoinduced electron transfer blocking and micellization: Application to the development of novel highly sensitive microwell spectrofluorimetric assay for analysis of dosage forms and urine samples

This study describes the enhancement of the weak native fluorescence of loratadine (LOR) by dual strategy via photoinduced electron transfer (PET) blocking followed by micellization into sodium dodecyl sulfate micelles. The enhanced fluorescence was employed as a basis for the development of a novel microwell spectrofluorimetric assay (MW-SFA) for the determination of LOR in its pharmaceutical dosage forms and urine samples. The assay was conducted in 96-microwell assay plates, and the enhanced fluorescence signals were measured by a microplate reader at 290 and 435 nm for excitation and emission, respectively. The optimum conditions of the assay were established, calibration curve was generated, and the linear regression equation was computed. The relation between the fluorescence signals and LOR concentrations was linear with good determination coefficients (0.9992) in the range of 10 - 2000 ng mL-1. The assay limits of detection and quantitation were 4.1 and 12.5 ng mL-1, respectively. The precision was satisfactory, with values of relative standard deviation not exceeding 1.68%, and the assay's accuracy was ≥ 99.1%. The proposed was successfully applied to the analysis of LOR in its pharmaceutical dosage forms with acceptable accuracy and precision. The label claims were 99.3 - 100.5% (±0.95 - 1.59%). Statistical analysis comparing the results of the proposed assay with those obtained by a reported pre-validated assay revealed no significant difference between both methods in terms of the accuracy and precision at the 95% confidence level. The assay was also applied to the analysis of urine samples containing LOR with accuracy ≥ 98.24%. The greenness of the proposed assay was confirmed by three efficient metric tools. In overall conclusion, the proposed assay is characterized by high sensitivity, procedure simplicity, and high throughput, enabling the simultaneous analysis of many samples in a short time. Therefore, it is a valuable tool for rapid routine application in pharmaceutical quality control units and clinical laboratories for the determination of LOR.

A recent overview of surfactant-drug interactions and their importance

This review focuses on the self-aggregation properties of different drugs, as well as on their interaction with anionic, cationic, and gemini surfactants. The interaction of drugs with surfactants has been reviewed concerning conductivity, surface tension, viscosity, density, and UV-Vis spectrophotometric measurements, and their relation with critical micelle concentration (CMC), cloud point, and binding constant. The conductivity measurement technique is used for the micellization of ionic surfactants. Cloud point studies can be used for the non-ionic, and also for certain ionic surfactants. Usually, surface tension studies are mostly employed for non-ionic surfactants. The degree of dissociation that is determined is used to evaluate thermodynamic parameters of micellization at various temperatures. The effect of external parameters like temperature, salt, solvent, pH, etc., is discussed for thermodynamics parameters using recent experimental works on drug-surfactant interactions. Consequences of drug-surfactant interaction, condition of drugs during interaction with surfactants, and applications of drug-surfactant interaction are being generalized which reflects current and future potential uses of drug-surfactant interactions.

Adsorption characteristics of antibiotics on microplastics: The effect of surface contamination with an anionic surfactant

Microplastics and antibiotics are common, typical pollutants, and they can cause compound pollution where they coexist in the environment. Surfactants in the environment can change the interface characteristics of pollutants, and then drive the change of environmental behavior of pollutants. In this paper, we studied the physicochemical properties of complexes of polystyrene (PS) and polyethylene (PE) contaminated with sodium dodecyl benzene sulfonate (SDBS); the complexes are referred to as SPS and SPE, respectively. Taking oxytetracycline (OTC) and norfloxacin (NOR) as representatives of broad-spectrum antibiotics, the effects of SDBS on the adsorption behavior of PS and PE were analyzed and possible mechanisms were proposed. The results showed that SDBS could effectively combine with PS and PE to enhance the surface electronegativity and reduce the Brunner-Emmett-Teller (BET) specific surface area and porosity. The crystal structure remained basically unchanged, and the surface functional groups changed slightly. SDBS greatly enhanced the saturated adsorption capacities of PS and PE for OTC and NOR, and made adsorption easier, which reduced the Gibbs free energy of the adsorption system. The adsorption behaviors of SPS and SPE for the two antibiotics were consistent with the Elovich kinetic model and Sips isothermal model. SDBS enhanced the hydrophilicity of the microplastics, which facilitated their adsorption of antibiotics dissolved in water. SDBS could directly combine with antibiotics to form a complex, further increasing the adsorption capacity of the microplastics for antibiotics. The -SO₃H in SDBS could combine with oxygen-containing functional groups and -NH₂ in OTC and NOR. Non-ionic covalent bonds, electrostatic interactions, and hydrophobic attraction between the alkyl chain and benzene ring also played a role in adsorption. SDBS made it possible for MPs to load more types and quantities of pollutants and change their preferential adsorption selectivity, which significantly aggravated the environmental hazards.